Abstract
Background. Ovarian tumors in the pediatric population are most likely to be of germ cell origin. However, serous tumors have also been reported in adolescent patients. Case. A 14-year-old girl was diagnosed with stage IIIc low-grade ovarian cancer. Her serum CA-125 was elevated preoperatively and was a marker for recurrence of disease. Five months after completing standard chemotherapy, she developed recurrent disease, which progressed despite hormonal therapy. She then developed toxicity on liposomal doxorubicin (Doxil) and is now receiving hospice care. Conclusion. Low-grade serous adenocarcinoma of the ovary can present as advanced disease and should be considered in the differential diagnosis of an ovarian mass in an adolescent patient.
Original language | English (US) |
---|---|
Pages (from-to) | 104-106 |
Number of pages | 3 |
Journal | Gynecologic oncology |
Volume | 80 |
Issue number | 1 |
DOIs | |
State | Published - 2001 |
Keywords
- Adjuvant chemotherapy
- Ovarian cancer
- Serous adenocarcinoma
ASJC Scopus subject areas
- Oncology
- Obstetrics and Gynecology